• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

dkNET Webinar "Metabolomics Workbench – A gateway to multiomics integration and disease biology"


Join dkNET Webinar on Friday, February 28, 2025, 11 am - 12 pm PT


Presenter: Shankar Subramaniam, PhD, Distinguished Professor of Bioengineering, Bioinformatics and Systems Biology, Computer Science and Engineering, Cellular and Molecular Medicine, and Nano Engineering, University of California San Diego


Abstract

In less than a quarter century metabolomics has emerged as the sine qua non of omics-driven physiology and pathology. In this period our ability to detect and measure metabolites has transitioned from tens to hundreds of thousands in a single experiment. Such a technological revolution rivals that of other omics and is beginning to provide detailed insights into normal and diseased physiological functions of cells and tissues. Further new standards, data analytics and tools are making metabolomics indispensable in modern life science research. In this talk, I will introduce the Metabolomics Workbench (https://www.metabolomicsworkbench.org/and all the resources that are available to the research community in finding, accessing, and using the metabolomics data and its integration with other omics data. I will demonstrate how metabolomics has become an essential element in systems biology approaches to cell and tissue function.


Acknowledgements: Research presented in this talk is supported by grants from the National Institutes of Health, NIDDK, NHLBI, and OD.


The Top 4 Questions that Metabolomics Workbench Can Answer:

1. How can you access metabolomics data pertinent to human diseases, specifically of interest to diseases relevant to diabetes, digestive, and kidney diseases?

2. What are the most important metabolomic abnormalities that characterize fatty liver diseases?

3. Can I develop hypotheses on integrative omics mechanisms associated with liver cancer?

4. What tools are available for analyses of metabolomics data?


Dial-in Information: https://uchealth.zoom.us/meeting/register/SgG2fDHXRiOGpEZvGFXoGg


Upcoming webinars schedule: https://dknet.org/about/webinar


X

Are you sure you want to delete that component?